Question

A patient with non-hodgkin lymphoma arrives for an infusion of rituximab. the nurse knows the parient is at high risk for actuon base on

Answer 1

patient's history of previous reactions to rituximab or other medications presence of certain medical conditions, or

laboratory results that indicate a high risk of allergic reaction

Step-by-step explanation:

Rituximab targets and binds to a protein called CD20 on the surface of cancer cells, leading to cell death. slows or stops cancer growth.

CD20 is located on mature B cells (white blood cells) in the bone marrow

Rituximab binds to a surface protein, called CD20 Once bound, the antibody activates the body's immune system, which then attacks the cancer cells.

metaAI

cancer.gov